Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1936-1941
Published online before print August 29, 2002, doi: 10.1161/01.ATV.0000035405.16217.86
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v23,p705)
Right arrow All Versions of this Article:
22/11/1936    most recent
01.ATV.0000035405.16217.86v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burke, A. P.
Right arrow Articles by Virmani, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burke, A. P.
Right arrow Articles by Virmani, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cardiac Arrest
*Coronary Artery Disease
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1936.)
© 2002 American Heart Association, Inc.


Thrombosis

Increased Serum Homocysteine and Sudden Death Resulting from Coronary Atherosclerosis With Fibrous Plaques

Allen P. Burke; V. Fonseca; Frank Kolodgie; Arthur Zieske; Louis Fink; Renu Virmani

From the Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC (R.V., A.P.B., F.K.); the Veteran’s Affairs Medical Center (L.F., V.F.), Little Rock, Ark; and Louisiana State University (A.Z.), New Orleans, La.

Correspondence to Renu Virmani, MD, Chairperson, Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC. E-mail virmani{at}afip.osd.mil

Introduction— Modest elevations of total homocysteine have been associated with increased risk for coronary atherosclerosis but correlation between elevated homocysteine and plaque morphology has not been described in humans.

Methods— We determined serum homocysteine at postmortem from 87 men with coronary thrombus (62 of whom were diagnosed as acute), from 35 men with severe coronary disease without thrombus, and from 46 controls. In coronary deaths, atherosclerotic plaques at the sites of maximal luminal narrowing of the four epicardial coronary arteries were classified as fibrous plaques, fibrous cap atheromas, thin-cap atheromas, and healed ruptures, and macrophage infiltration was assessed semiquantitatively.

Results— Median serum homocysteine postmortem as a result of acute thrombus was 10.4 µmol/L (P=0.4 versus controls), 12.1 µmol/L in men with organized thrombi (P=0.1 versus controls), 15.6 µmol/L in men without thrombus (P=0.007 versus controls), and 9.8 µmol/L in controls. The median homocysteine was 12.1 µmol/L in 65 men with healed infarcts (P=0.03 versus controls). The number of fibrous plaques was associated with log-normalized homocysteine (P=0.004), independent of age, albumin, smoking, hypertension, and serum cholesterol. Homocysteine levels in the upper tertile (>15 µmol/L) were associated with sudden death without acute or organized thrombus (odds ratio 3.8, P=0.03) independent of age and other risk factors; the coexistence of diabetes increased the association (odds ratio 25.1, P=0.009, versus lowest tertile <=8.5 µmol/L).

Conclusions— Increased serum homocysteine is associated with sudden death in the absence of acute coronary thrombosis, especially with concomitant diabetes, and with the presence of lipid-poor, fibrous plaques.


Key Words: homocysteine • diabetes • coronary artery disease • sudden death • thrombosis




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. S. Moshal, M. Kumar, N. Tyagi, P. K. Mishra, N. Metreveli, W. E. Rodriguez, and S. C. Tyagi
Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1
Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H887 - H892.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. S. Moshal, S. M. Tipparaju, T. P. Vacek, M. Kumar, M. Singh, I. E. Frank, P. K. Patibandla, N. Tyagi, J. Rai, N. Metreveli, et al.
Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H890 - H897.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. Zhou, G. H. Werstuck, S. Lhotak, Y. Y. Shi, V. Tedesco, B. Trigatti, J. Dickhout, A. K. Majors, P. M. DiBello, D. W. Jacobsen, et al.
Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice
FASEB J, July 1, 2008; 22(7): 2569 - 2578.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. W. H. Woo, Y. L. Siow, G. N. Pierce, P. C. Choy, G. Y. Minuk, D. Mymin, and K. O
Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors
Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E1002 - E1010.
[Abstract] [Full Text] [PDF]